Delivery Order SPE2DB24D3014-SPE2DB25FKTGS
- Not listed
- The Defense Logistics Agency awarded a $1,046.29 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 capsules of Cefdinir 300 mg, an oral antibiotic commonly used to treat bacterial infections. This delivery order was competitively awarded with no set-aside designation and carries an ultimate completion date of July 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Cefdinir 300 mg capsules (60-count units) with a contract ceiling value of $1,774.40. This firm fixed price delivery order, with an ultimate completion date of September 2, 2025, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,331.74 firm fixed price delivery order to AmerisourceBergen Drug Corp for Cefdinir 300 mg capsules (60-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Cefdinir 300 mg capsules (60-count units) under a firm fixed-price contract with a ceiling value of $1,141.79. This non-set-aside award represents a competitive delivery order executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026. The ultimate completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Cefdinir 300 mg capsules (60-count units) with a ceiling value of $7,070.12. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Cefdinir 300 mg capsules (60-count) at a ceiling value of $1,347.10. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 10, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Cefdinir 300 mg capsules (60-count units) valued at $8,449.72. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cefdinir 300 mg capsules (60-count units) with a ceiling value of $1,839.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract represents no set-aside designation and is issued as a child order under a larger contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cefdinir 300 mg capsules (60-count units) under a firm fixed-price contract valued at $1,064.64. The award, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competitive delivery order executed without a set-aside designation. Performance will be completed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- This federal contract award, valued at $8,009.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of 4,568,033,991 units of the antibiotic medication Cefdinir 300 mg capsules. The contract has a firm fixed price and an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKTGSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,733.84 to AmerisourceBergen Drug Corp for 60 capsules of Cefdinir 300 mg, an oral antibiotic commonly prescribed for bacterial infections. The contract, awarded April 30, 2025, with completion by May 1, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.9 million through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this comprehensive global pharmaceutical support vehicle. The company's contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 4/30/25 |